Compare Edwards Lifesciences Corporation Common Stock (EW) vs Banco Santander SA (SAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Banco Santander SA — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $48.56B), while Banco Santander SA trades at $13.5 (market cap $192.86B). The key difference: Banco Santander SA is far larger — about 4× Edwards Lifesciences Corporation Common Stock's market cap, and Banco Santander SA pays a 2.06% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | SAN | |
|---|---|---|
Market Cap | $48.56B | $192.86B |
Volume | 6,520,488 | 10,644,519 |
Sector | Health | Financials |
52-Week High | $95.18 | $15.05 |
52-Week Low | $72.65 | $9.65 |
Enterprise Value | $45.01B | $360.86B |
Typical Hold Time | — | 55 Days |
Dividend Yield | — | 2.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Banco Santander (SAN) trades at $13.66, down 2.5% with bearish technical signals despite strong profitability metrics including 26.25% net margin and 16.07% ROE. The company completed its Webster Financial acquisition in August 2026, expanding U.S. presence while reporting record quarterly profits. Cash flow trends show recent operational challenges with negative $28.13B net cash flow in 2024, though revenue growth remains steady at $60.02B for 2025.
SAN presents a mixed outlook with strong fundamental performance offset by technical weakness. The acquisition-driven growth strategy and technological transformation support long-term value, but negative cash flows and high debt levels ($288.23B long-term debt) pose execution risks. Analyst consensus remains moderately bullish with 64% buy ratings, suggesting potential upside if operational efficiency improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Banco Santander SA
Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →
